Non-Small Cell Lung Cancer
Celecoxib can be safely used concurrently with thoracic radiotherapy
Published in Clinical Trials Week, June 27th, 2005
According to a study from the United States, "Preclinical observations that selective cyclooxygenase-2 inhibitors enhance in vitro cell radiosensitivity and in vivo tumor radioresponse led to clinical trials testing therapeutic efficacy of these agents."
Z.X. Liao and associates at the University of Texas, MD Anderson Cancer Center in Houston explained, "Our study was designed to determine whether the COX-2 inhibitor celecoxib could be safely administered in doses within those approved by the Food and Drug Administration when used concurrently with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Trials Week
Source: Clinical Trials Week (2005-06-27)
More Articles from Clinical Trials Week
- Interferon
Peginterferon alfa-2b plus ribavirin treatment evaluated in children with HPC - Prostate Cancer
Combining recombinant cancer vaccine with radiotherapy is a safe regimen - Psoriatic Arthritis
Addition of cyclosporin to methotrexate treatment has limited effects - Acute Radiation Syndrome
New drug being developed for the treatment of acute radiation syndrome - Addiction Medicine
Harold Urschel to investigate protocols for treating methamphetamine dependence - Addiction Medicine
Lipid oxidative stress evaluated in bariatric candidates with NAFLD - More from this issue of Clinical Trials Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
